StockNews.AI
NOVT
StockNews.AI
175 days

Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024

1. Novanta reported Q4 2024 and full-year earnings with rising revenue. 2. Revenue grew from $211.6M to $238.1M (Q4) and $881.7M to $949.2M (FY).

+8.3%Current Return
VS
-0.71%S&P 500
$138.302/25 07:14 AM EDTEvent Start

$149.7802/26 01:54 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Bullish?

The revenue increase in both quarterly and annual figures indicates operational strength and investor confidence. Similar earnings beats in tech and medical equipment sectors have previously driven positive stock movements in companies like Intuitive Surgical (ISRG).

How important is it?

The material revenue growth is significant for NOVT's outlook, likely driving investor sentiment in a competitive industry.

Why Short Term?

Earnings announcements typically trigger immediate market reactions, influencing near-term stock performance based on investor sentiment.

Related Companies

BEDFORD, Mass.--(BUSINESS WIRE)--Novanta Inc. (Nasdaq: NOVT) (“Novanta” or the “Company”), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights Three Months Ended December 31,   Year Ended December 31, (In millions, except per share amounts)   2024       2023       2024       2023   GAAP                       Revenue $ 238.1     $ 211.6     $ 949.2     $ 881.7   O.

Related News